Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.82 USD | +15.59% | +30.45% | 0.00% |
May. 08 | Earnings Flash (CORZ) CORE SCIENTIFIC Posts Q1 Revenue $179.3M | MT |
May. 08 | Core Scientific, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- For the past twelve months, EPS forecast has been revised upwards.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- CORZ Stock
- Ratings Core Scientific, Inc.